Precision medicine in cardiology
- PMID: 27356875
- DOI: 10.1038/nrcardio.2016.101
Precision medicine in cardiology
Abstract
The cardiovascular research and clinical communities are ideally positioned to address the epidemic of noncommunicable causes of death, as well as advance our understanding of human health and disease, through the development and implementation of precision medicine. New tools will be needed for describing the cardiovascular health status of individuals and populations, including 'omic' data, exposome and social determinants of health, the microbiome, behaviours and motivations, patient-generated data, and the array of data in electronic medical records. Cardiovascular specialists can build on their experience and use precision medicine to facilitate discovery science and improve the efficiency of clinical research, with the goal of providing more precise information to improve the health of individuals and populations. Overcoming the barriers to implementing precision medicine will require addressing a range of technical and sociopolitical issues. Health care under precision medicine will become a more integrated, dynamic system, in which patients are no longer a passive entity on whom measurements are made, but instead are central stakeholders who contribute data and participate actively in shared decision-making. Many traditionally defined diseases have common mechanisms; therefore, elimination of a siloed approach to medicine will ultimately pave the path to the creation of a universal precision medicine environment.
Similar articles
-
Future of Personalized Cardiovascular Medicine: JACC State-of-the-Art Review.J Am Coll Cardiol. 2018 Dec 25;72(25):3301-3309. doi: 10.1016/j.jacc.2018.09.079. J Am Coll Cardiol. 2018. PMID: 30573033 Review.
-
Precision Medicine and Personalized Medicine in Cardiovascular Disease.Adv Exp Med Biol. 2018;1065:589-605. doi: 10.1007/978-3-319-77932-4_36. Adv Exp Med Biol. 2018. PMID: 30051409 Review.
-
From genetics to smart watches: developments in precision cardiology.Nat Rev Cardiol. 2019 Feb;16(2):72-73. doi: 10.1038/s41569-018-0149-y. Nat Rev Cardiol. 2019. PMID: 30568275 Free PMC article. Review.
-
Strengths and Opportunities of Network Medicine in Cardiovascular Diseases.Circ J. 2020 Jan 24;84(2):144-152. doi: 10.1253/circj.CJ-19-0879. Epub 2019 Dec 21. Circ J. 2020. PMID: 31866635
-
Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.J Cardiovasc Transl Res. 2015 Nov;8(8):466-74. doi: 10.1007/s12265-015-9657-x. Epub 2015 Oct 9. J Cardiovasc Transl Res. 2015. PMID: 26453460 Review.
Cited by
-
Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies.Front Cardiovasc Med. 2021 Dec 22;8:788062. doi: 10.3389/fcvm.2021.788062. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 35004898 Free PMC article. Review.
-
AI-Aided Disease Prediction in Visualized Medicine.Adv Exp Med Biol. 2023;1199:107-126. doi: 10.1007/978-981-32-9902-3_6. Adv Exp Med Biol. 2023. PMID: 37460729
-
Multimodality imaging for the prevention of cardiovascular events: Coronary artery calcium and beyond.Cardiovasc Diagn Ther. 2021 Jun;11(3):840-858. doi: 10.21037/cdt-19-654. Cardiovasc Diagn Ther. 2021. PMID: 34295709 Free PMC article. Review.
-
The Role of Efferocytosis in Atherosclerosis.Circulation. 2017 Jan 31;135(5):476-489. doi: 10.1161/CIRCULATIONAHA.116.025684. Circulation. 2017. PMID: 28137963 Free PMC article.
-
Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?Circulation. 2024 Nov 19;150(21):1720-1731. doi: 10.1161/CIRCULATIONAHA.124.070081. Epub 2024 Nov 18. Circulation. 2024. PMID: 39556656 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources